[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356319-105":59,"doc-detail-356319-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cxcl12-derived-from-cancer-associated-fibroblasts-mediates-dysfunctional-intratumoral-adaptive-immunity-in-diabetic-pancreatic-adenocarcinoma","CXCL12 derived from cancer-associated fibroblasts mediates dysfunctional intratumoral adaptive immunity in diabetic pancreatic adenocarcinoma","","Diabetes mellitus (DM) influences pancreatic adenocarcinoma development, yet the DM-linked immune features in PAAD remain unclear. This study characterizes the immune landscape in diabetic PAAD and identifies mechanisms driven by cancer-associated fibroblast (CAF) signals. RNA-sequencing and multiple immune-infiltration algorithms were integrated with multicolor immunofluorescence, in vitro functional assays, and a mixed cell animal model. Results show CXCL12 correlates with B- and CD8+ T-cell abundance and immune phenotype transformation, and CXCL12High CAFs promote immune suppression. CXCL12–CXCR4 blockade by plerixafor provides therapeutic benefit in tumor models.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cxcl12-derived-from-cancer-associated-fibroblasts-mediates-dysfunctional-intratumoral-adaptive-immunity-in-diabetic-pancreatic-adenocarcinoma/356319/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cxcl12-derived-from-cancer-associated-fibroblasts-mediates-dysfunctional-intratumoral-adaptive-immunity-in-diabetic-pancreatic-adenocarcinoma/356319.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What immune defect is observed in diabetic pancreatic cancer in this study?","Question",{"text":112,"@type":113},"Diabetic pancreatic cancer shows an apparently flourishing but functionally defective immune state, characterized by CD22+ B cells and TIGIT+ CD8+ T cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is CXCL12 linked to immune phenotype changes in diabetic PAAD?",{"text":117,"@type":113},"CXCL12 is significantly associated with the abundance and immune phenotype transformation of B and CD8+ T cells, with consistent findings across multiple computational algorithms.",{"name":119,"@type":110,"acceptedAnswer":120},"What therapeutic strategy targeting CXCL12–CXCR4 was tested, and what were the outcomes?",{"text":121,"@type":113},"The study used plerixafor to block the CXCL12–CXCR4 axis, showing therapeutic effects in subcutaneous tumor models.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356319,1790153881,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Cellular Oncology (2026) 49:36  \n[https://doi.org/10.1007/s13402-026-01](https://doi.org/10.1007/s13402-026-01)165-x  \nRESEARCH  \nCXCL12 derived from cancer-associated fibroblasts mediates dysfunctional intratumoral adaptive immunity in diabetic pancreatic adenocarcinoma  \nJialun Wang1 · Yue Zhou1 · Xiaoxuan Han1 · Yihan Zhao1 · Aotian Chen1 · Yu Chen1 · Shu Zhang1 · Ying Lv1 · Lei Wang1  \nReceived: 22 August 2025 / Accepted: 15 January 2026 © The Author(s) 2026  \nAbstract  \nBackground Diabetes mellitus (DM) affects the occurrence and progression of pancreatic adenocarcinoma (PAAD), but the DM-related immune characteristic in PAAD remains unclear. This study aimed to elucidate the immune landscape and underlying mechanism in diabetic PAAD.  \nMethods RNA-sequencing data from primary sorted cancer-associated fibroblasts (CAFs) and TCGA database were used to screen out differentially expressed genes (DEGs), and enrichment analyses were performed to identify key pathways. xCell, Timer, Estimate, Quantiseq, and MCPcounter algorithms were applied to assess intratumoral immune infiltration, which was meanwhile verified by multicolor immunofluorescence of clinical samples. In vitro experiments, including proliferation assay and immune phenotype identification, were carried out to confirm the impact of the key gene on immune reprogramming. An animal model of mixed injection of pancreatic stellate cells (PSCs) and pancreatic cancer cells was constructed to validate in vivo effects of involved pathway in diabetic pancreatic cancer.  \nResults Screened DEGs were enriched in several immunomodulatory pathways. The immunity in diabetic pancreatic cancer was shown to be seemingly flourishing but functionally defective, characterized by CD22+ B cells and TIGIT+ CD8+ T cells. Correlation analyses indicated that CXCL12 was significantly associated with the abundance and immune phenotype transformation of B and CD8+ T cells, with consistent results across multiple algorithms. More CXCL12High CAFs were detected in diabetic PAAD patients and mice. Meanwhile, the treatment of CXCL12High PSCs promoted the immune-suppressive phenotype of B and CD8+ T cells in both in vitro and in vivo experiments, and the blockade of CXCL12–CXCR4 axis by plerixafor showed therapeutic effects in subcutaneous tumor models.  \nConclusions Our results delineated a distinct immune-suppressive landscape mediated by CAF-derived CXCL12 in diabetic PAAD individuals, which may help guide treatment decisions and predict immunotherapy response.  \nJialun Wang, Yue Zhou, Xiaoxuan Han, and Yihan Zhao contributed equally to this work.  \n􀀍 Yu Chen[chenyu01_29@163.com](chenyu01_29@163.com)  \n􀀍 Shu Zhang [zhangsgastro@nju.edu.cn](zhangsgastro@nju.edu.cn)  \n􀀍 Ying Lv [lvying@njglyy.com](lvying@njglyy.com)  \n􀀍 Lei Wang [leiwang9631@nju.edu.cn](leiwang9631@nju.edu.cn)  \nJialun Wang  \n[wangjlgastro@163.com](wangjlgastro@163.com)  \n1  \nYue Zhou  \n[dr_zhou2021@163.com](dr_zhou2021@163.com)[ ](dr_zhou2021@163.com)Xiaoxuan Han [hanxx0430@163.com](hanxx0430@163.com)[ ](hanxx0430@163.com)Yihan Zhao [zyhtjtmu@163.com](zyhtjtmu@163.com)[ ](zyhtjtmu@163.com)Aotian Chen  \n[atchen@smail.nju.edu.cn](atchen@smail.nju.edu.cn)  \nDepartment of Gastroenterology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, China  \n1 3  \nGraphical Abstract  \nKeywords Pancreatic cancer · Diabetes mellitus · Intratumoral immunity · CXCL12 · Cancer-associated fibroblast  \nAbbreviations  \nAGE Advanced glycation end product  \nAJCC American Joint Committee on Cancer classification  \nATCC American Type Culture Collection  \nBSA Bovine serum albumin Breg B regulatory cell  \nCAF Cancer-associated fibroblast DC Dendritic cell  \nDEG Differentially expressed gene DM Diabetes mellitus  \nElisa Enzyme-linked immunosorbent assay EMT Epithelial-mesenchymal transition FBS Fetal bovine serum  \nGO Gene Ontology  \nIGF-1 IHC  \nKEGG  \nmPSC  \nNK  \nOB-R  \nOS  \nPAAD  \nPPI  \nPSC  \nqPCR  \nROS  \nSD","cbCainujdQDJRq2m","https://ap.wps.com/l/cbCainujdQDJRq2m","pdf",19089900,18,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Keywords\n# Abbreviations\n# Introduction","[{\"question\":\"What immune defect is observed in diabetic pancreatic cancer in this study?\",\"answer\":\"Diabetic pancreatic cancer shows an apparently flourishing but functionally defective immune state, characterized by CD22+ B cells and TIGIT+ CD8+ T cells.\"},{\"question\":\"How is CXCL12 linked to immune phenotype changes in diabetic PAAD?\",\"answer\":\"CXCL12 is significantly associated with the abundance and immune phenotype transformation of B and CD8+ T cells, with consistent findings across multiple computational algorithms.\"},{\"question\":\"What therapeutic strategy targeting CXCL12–CXCR4 was tested, and what were the outcomes?\",\"answer\":\"The study used plerixafor to block the CXCL12–CXCR4 axis, showing therapeutic effects in subcutaneous tumor models.\"}]","CXCL12 derived from cancer-associated fibroblasts mediates dysfunctional intratumoral adaptive immunity in diabetic pancreatic adenocarcinoma | PDF",1790124673,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cbd2b2a05981b6aa0a9ce5f3e023a6b6.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b88411117ac34fa770bb89b014fb2c9d.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/28e21f232e9ac8eb81b7e2cca7567d0a.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/97b06de0fa0fceacdf5325990551db12.webp",980,1301]